Published on : Aug 11, 2017
Albany, New York, August 11, 2017: Melanoma of the uveal tract (iris, ciliary body, and choroid), though rare, is the most common primary intraocular malignancy in adults. Market Research Hub (MRH) has recently added a research study titled as “Uveal Melanoma-Market Insights, Epidemiology and Market Forecast-2025” to its vast report archive. The major objective of the study is to present detailed market insights and epidemiology study on Uveal melanoma covering seven major markets. It also allows understanding of the historical and projected epidemiological data for the identified prevalent cases of Uveal Melanoma across the world.
Geographically, the report provides an overview of the disease and exhaustive research related to uveal melanoma disorder for seven major markets for the study period undertaken from 2015-2025. The 7 major markets analyzed in this study are United States, EU 5 (Germany, Spain, Italy, France and the United Kingdom) and Japan. In the initial section, the report provides an understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Uveal Melanoma.
The first section of the study highlights uveal melanoma overview along with its symptoms, staging, diagnosis and treatment. Intraocular melanoma is a disease in which malignant (cancer) cells form in the tissues of the eye. The middle layer, where intraocular melanoma forms, is known as uvea or uveal tract which has three main parts: Iris, Ciliary body and Choroid. Iris melanomas have the best prognosis, whereas melanomas of the ciliary body have the worst. Most of the uveal tract melanomas originate in the choroid; the ciliary body is less commonly a site of derivation, and the iris is the slightest. It is diagnosed in about 2,500 adults every year in the United States and occurs most often in lightly pigmented individuals with a median age of 55 years.
According to analyst’s findings, the forecasted patient population of Uveal melanoma will grow at a rapid rate from 2015 to 2025. Also, the 7MM market size is estimated to reach a high value by the end of 2025. The report also analyzes that the main factors in shaping treatment for eye melanoma include the location and size of cancer, as well as the probability of saving vision in the eye. The primary goals of treating the eye tumor include preventing metastasis, sparing the eye and preserving vision.
Moreover, the market outlook also provides understanding of country specific revenue and market share by evaluating performance of the current therapies and thorough potential uptake of new products. Additionally, the report highlights the frontrunners, the drivers and barriers for the Uveal Melanoma market, as well as treatment algorithm, current treatments & advancements are included. Additionally, the chapters including marketed products highlight the advantages and disadvantages associated with therapies associated with Uveal Melanoma.
Request a Sample with TOC in a PDF format : http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265939
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : firstname.lastname@example.org